Beyond Kickbacks: More Questions About Unnecessary Cardiovascular Tests

On the front page of the Wall Street Journal today is an important story about a fast-growing company accused of giving kickbacks to physicians who order the company’s tests measuring a wide variety of cardiovascular biomarker tests. But the article leaves one major question unasked: even if the company played fully by the rules, are most of the tests medically necessary?

In their story John Carreyrou and Tom McGinty write about a government investigation into Health Diagnostic Laboratory Inc. (HDL), which was started in 2008 and had $383 million in revenue last year. HDL sells tests that measure cardiovascular biomarkers and “bundles together up to 28 tests it performs on a vial of blood, receiving Medicare payments of $1,000 or more for some bundles.”

Click here to read the full post on Forbes.

 

Leave a Reply

%d bloggers like this: